SCHEMBL920183

SCHEMBL920183

NP(N)(=O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1685372 0.88
SCHEMBL15044898 0.78
SCHEMBL3823153 0.78
SCHEMBL107367 0.78
SCHEMBL10836470 0.78
Hydrochloric Acid SCHEMBL11037228 0.75
Ammonia Solution, Strong SCHEMBL11778479 0.75
SCHEMBL50123 0.72
SCHEMBL17004026 0.72
SCHEMBL992304 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154504-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA PROQR THERAPEUTICS II B.V. (NL) 2025-05-15 US claimed
US-20250084411-A1 Antisense Nucleic Acid Sumitomo Pharma Co., Ltd. (JP) 2025-03-13 US claimed
EP-4479535-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA ProQR Therapeutics II B.V. (NL) 2024-12-25 EP claimed
EP-4349987-A1 ANTISENSE NUCLEIC ACID Sumitomo Pharma Co., Ltd. (JP) 2024-04-10 EP claimed
WO-2023152371-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA PROQR THERAPEUTICS II B.V. (NL) 2023-08-17 WO claimed
US-20230039928-A1 Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease PROQR THERAPEUTICS II B.V. (NL) 2023-02-09 US claimed
WO-2022250155-A1 ANTISENSE NUCLEIC ACID 住友ファーマ株式会社 2022-12-01 WO claimed
EP-4081638-A1 ANTISENSE OLIGONUCLEOTIDES FOR NUCLEOTIDE DEAMINATION IN THE TREATMENT OF STARGARDT DISEASE ProQR Therapeutics II B.V. (NL) 2022-11-02 EP claimed
CN-109640650-B Compositions containing urease inhibitors 罗地亚经营管理公司 2022-07-12 CN claimed
WO-2021130313-A1 ANTISENSE OLIGONUCLEOTIDES FOR NUCLEOTIDE DEAMINATION IN THE TREATMENT OF STARGARDT DISEASE PROQR THERAPEUTICS II B.V. (NL) 2021-07-01 WO claimed
US-20210189392-A1 S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS ALIGOS THERAPEUTICS, INC. 2021-06-24 US claimed
WO-2021119325-A1 S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS ALIGOS THERAPEUTICS, INC. (US) 2021-06-17 WO claimed
EP-0119495-B1 S-ARYL AND S-ALIPHATIC DIAMIDOPHOSPHOROTHIOLATES AS UREASE INHIBITORS AND UREASE INHIBITED UREA BASED FERTILIZER COMPOSITIONS ALLIED CORPORATION (US) 1986-07-02 EP claimed
US-4537614-A PLANT GROWTH REGULATORS ALLIED CORPORATION (US) 1985-08-27 US claimed
EP-0119495-A1 S-aryl and S-aliphatic diamidophosphorothiolates as urease inhibitors and urease inhibited urea based fertilizer compositions ALLIED CORPORATION (US) 1984-09-26 EP claimed
EP-0002826-B1 NOVEL PHOSPHORAMIDOTHIOATE DERIVATIVES, PESTICIDAL COMPOSITIONS CONTAINING THEM, PROCESSES FOR PREPARING THE NOVEL DERIVATIVES AND THE USE OF THE NOVEL DERIVATIVES FOR COMBATING PESTS ROHM AND HAAS COMPANY (US) 1983-06-01 EP claimed
US-20260146249-A1 ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP VICO THERAPEUTICS B.V. (NL) 2026-05-28 US disclosed
WO-2026099473-A1 OLIGONUCLEOTIDES WITH NEW INTERNUCLEOSIDE LINKAGE VICO THERAPEUTICS B.V. (NL) 2026-05-15 WO disclosed
EP-0002826-A1 Novel phosphoramidothioate derivatives, pesticidal compositions containing them, processes for preparing the novel derivatives and the use of the novel derivatives for combating pests ROHM AND HAAS COMPANY (US) 1979-07-11 EP disclosed
US-4087430-A Pyridyl-phosphonamidothioates, pyridylphosphorodiamidothioates, oxy analogues thereof and derivatives thereof THE DOW CHEMICAL COMPANY (US) 1978-05-02 US disclosed